Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing.

In trading on Tuesday, shares of Johnson & Johnson (Symbol: JNJ) crossed above their 200 day moving average of $156.46, changing hands as high as $157.44 per share. Johnson & Johnson shares are ...

Johnson & Johnson's niraparib combo significantly delays prostate cancer progression in HRR-altered patients with strong phase III data.

JNJ-1900, an immune-stimulating radiation sensitizer designed to enhance the effects of hypofractionated radiation in small, targeted areas, is being investigated in a phase 1 study for patients with ...

Johnson & Johnson JNJ shared data from several cancer studies at the 2025 American Society of Clinical Oncology (ASCO) annual meeting on Tuesday. Here’s that the New Brunswick, New Jersey-based ...

Trusted Johnson & Johnson brands including Tylenol, Aveeno, Neutrogena, Listerine, and Band-Aid are set to fall under the new, independent company name in a next-chapter move of repurposing and ...

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and ...

The scale is logarithmic – that is, the severity of an event is about ten times greater for each increase in level of the scale. Events are considered in terms of: Impact on people and the environment ...

Johnson & Johnson's recent earnings beat expectations, with strong Medicine and MedTech growth. Read why I have a buy rating on JNJ stock.